Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phytoestrogen-Dhurakij Pundit University refers to an investigational botanical product derived from *Pueraria mirifica*, a Thai medicinal plant known as White Kwao Krua. The extract contains a variety of phytoestrogens, including isoflavonoids (such as puerarin, daidzin, and genistin), coumestans, and chromenes (notably miroestrol and deoxymiroestrol). These compounds function as natural selective estrogen receptor modulators (SERMs) that bind to estrogen receptors to mimic or modulate the effects of endogenous estrogen. Dhurakij Pundit University is evaluating the treatment in a Phase 2/3 clinical trial to determine its efficacy in improving serum lipid parameters—including triglycerides, total cholesterol, LDL, and HDL—in postmenopausal women with dyslipidemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pueraria mirifica extract.